PDA Letter Article

Innovative Tech Drives Drug Shortage Solutions

by Robert Guidos, Corning


Drug shortages are receiving renewed attention by regulators. At a November 2018 public meeting sponsored by the U.S. FDA, oncologists, pharmacists and other healthcare professionals reported the tremendous burden shortages place on the healthcare system, often with dire consequences for patients. During the meeting, FDA reported that the impact of shortages on public health remains “high,” revealing that the Agency is seeing increased numbers of shortages with longer durations and higher intensities. This uptick follows years of decline in drug shortages.